Gynuity Health Projects

Resources

Increasing women's choices in medical abortion: A study of misoprostol 400 μg swallowed immediately or held sublingually following 200 mg mifepristone

This article reports on results of a clinical trial evaluating two routes of misoprostol administration following mifepristone for early medical abortion. For gestations through 56 days since last menstrual period 400mcg of oral misoprostol performed better than a 400mcg sublingual dose when following 200mg mifepristone although not significantly so. Access the full abstract at European Society of Contraception and Reproductive Health, (Jun 2009) Vol. 14(3);169-75.

  • Topic: Medical Abortion
  • Type: Staff Publication
  • Author: Akın, A., Dabash, R., Dilbaz, B, Aktun, H., Dursun, P., Kıran, S., Aksan, G., Dogan, B., Winikoff, B.
  • Published: June 2009